mFluiDX
Enabling molecular detection anywhere
* Data source: Crunchbase
- Founded
- 2016
- Employees*
- 1-10
- Funding to Date*
- undisclosed
- Website
- mfluidx.com
Our vision is to integrate the informatics, such as the GPS data, test results, and patient information, into a cloud system. That would be very useful for local governments to track where the disease is coming from — and where it’s going.
According to the Brazilian Ministry of Health, only 34,000 out of 120,000 reported Zika cases were confirmed in 2016 because of difficulties testing for the disease
The mFluiDx platform is fully autonomous, smart-phone enabled unit ideal for on-site testing. Also, Injection molding allows mass production of chips at cost 1000 times lower than PCR. In addition, sothermal nucleic acid amplification allows sensitivity comparable to PCR. So, with quick and accurate results the platform allows real-time tracking of outbreak, conveying important information during most crucial times of outbreak.